A
Azienda Ospedaliera S. Croce e Carle | Cuneo Hospital - Hematology Department
Research site
(Unclaimed)
Site insights
Top conditions
Top treatments
Trabectedin
Gemcitabine
Tocilizumab
PLD
Doxorubicin
Exemestane
Docetaxel
EVerolimus
Fulvestrant
Letrozole
Curious how this site stacks up to its peers?
Data sourced from clinicaltrials.gov
Work at this site?
CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.
Active trials
2 of 22 total trials
Breast cancer is the most common form of cancer among women. For patients candidated for adjuvant chemotherapy and endocrine therapy the optimal timi...
Active, not recruiting
Breast Cancer
Drug: Anastrozole or Letrozole or Exemestane
The primary objective of this study is to demonstrate pharmacokinetic (PK) similarity ABP 234 with pembrolizumab.
Enrolling
Early-stage Non-squamous Non-small Cell Lung Cancer (NSCLC)
Drug: ABP 234
Drug: Pembrolizumab
Trial sponsors
C
A
I
M
M
A
Clinical trials
Research sites
Resources
Legal
© Copyright 2025 Veeva Systems